Undervalued Small Caps With Insider Buying

Results

207

33 new

Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.

207 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
AUBN
New
US$26.29-1.8%-5.6%US$92.0mn/a1.0n/a4.1%Banks
KINS
US$20.396.0%29.1%US$292.4mUS$21.509.520.8%1.0%Insurance
FNLC
US$35.554.9%40.5%US$399.9mn/a1.4n/a4.3%Banks
BMRC
US$28.41-0.2%25.2%US$465.2mUS$31.201.1102.8%3.5%Banks
PMZ.UN
CA$23.08-0.3%54.6%CA$2.7bCA$24.191.112.1%3.8%Real Estate
MDV
US$17.71-2.9%23.6%US$209.5mUS$18.671.1149.5%6.8%Real Estate
ONT
US$20.231.8%-9.0%US$740.1mUS$27.00165.298.9%n/aCommercial Services
SHBI
US$24.547.3%55.6%US$816.7mUS$25.751.38.1%2.3%Banks
PZA
CA$12.71-0.2%-21.7%CA$431.3mCA$12.0013.939.6%7.3%Consumer Services
SFC
CA$8.611.4%9.8%CA$1.2bCA$12.1932.353.0%4.9%Insurance
NXR.UN
CA$8.300%7.2%CA$815.5mCA$8.500.53.0%7.7%Real Estate
FTG
CA$23.00-1.5%102.3%CA$586.8mCA$29.7538.722.0%n/aTech
ILPT
US$8.73-4.4%62.0%US$603.3mUS$10.271.224.9%2.3%Real Estate
UNB
US$23.53-4.6%-13.5%US$108.4mn/a1.2n/a6.1%Banks
RCEL
US$4.44-3.7%-16.2%US$136.7mUS$9.071.964.1%n/aPharmaceuticals & Biotech
ANGX
US$3.92-6.4%-67.0%US$762.4mUS$8.001.959.6%n/aMedia
PAX
US$10.68-1.0%-23.4%US$1.7bUS$15.5723.934.4%6.1%Diversified Financials
SMWB
US$7.1614.0%-16.4%US$629.8mUS$5.802.2112.6%n/aSoftware
AVIA
Rp318.00-3.6%-30.3%Rp18.8tRp519.0010.45.9%6.9%Materials
BTPS
Rp990.00-2.9%-29.8%Rp7.6tRp1,416.500.711.0%9.3%Banks
1837
HK$1.58-5.4%100.0%HK$3.5bHK$2.1611.217.9%4.5%Food, Beverage & Tobacco
SDR
AU$3.300.3%-36.7%AU$930.4mAU$5.993.747.1%n/aSoftware
OCE
R71.916.2%37.3%R8.5bR90.0012.18.3%4.0%Food, Beverage & Tobacco
EW
₱11.78-0.3%-5.0%₱26.5b₱13.700.38.8%5.8%Banks
Page 1 of 6